Haemonetics Has Announced That For The First Time, Patients Have Been Treated With The Company's VASCADE MVP Venous Vascular Closure System In Germany, Marking The First Use Of The VASCADE System Portfolio In A European Country
Portfolio Pulse from Benzinga Newsdesk
Haemonetics Corporation (HAE) has announced that its VASCADE MVP Venous Vascular Closure System has been used for the first time in Germany. This marks the first use of the VASCADE system portfolio in a European country.
August 29, 2023 | 10:32 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Haemonetics' VASCADE system has been used for the first time in Germany, marking its entry into the European market. This could potentially open up new revenue streams for the company.
The use of Haemonetics' VASCADE system in Germany signifies its entry into the European market. This could potentially lead to increased sales and revenues for the company, positively impacting its stock price in the short term.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100